{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:15:27Z","timestamp":1784265327344,"version":"3.55.0"},"reference-count":44,"publisher":"American Society for Microbiology","issue":"4","license":[{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["(BT\/PR27895\/MED\/29\/1270\/2018 Dt. 02\/01\/19"],"award-info":[{"award-number":["(BT\/PR27895\/MED\/29\/1270\/2018 Dt. 02\/01\/19"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Microbiol Spectr"],"published-print":{"date-parts":[[2023,8,17]]},"abstract":"<jats:p>\n            <jats:named-content content-type=\"genus-species\">Staphylococcus aureus<\/jats:named-content>\n            , which causes the majority of nosocomial and community-acquired infections globally, is a WHO high-priority pathogen for antibiotic research and development. In addition to invasive infections, it is the causative agent of moderate to severe skin infections, with an increasing prevalence of infections caused by MDR strains such as methicillin-resistant\n            <jats:named-content content-type=\"genus-species\">S. aureus<\/jats:named-content>\n            (MRSA).\n          <\/jats:p>","DOI":"10.1128\/spectrum.05031-22","type":"journal-article","created":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T14:07:16Z","timestamp":1688998036000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":13,"title":["Oxiconazole Potentiates Gentamicin against Gentamicin-Resistant Staphylococcus aureus\n            <i>In Vitro<\/i>\n            and\n            <i>In Vivo<\/i>"],"prefix":"10.1128","volume":"11","author":[{"given":"Grace","family":"Kaul","sequence":"first","affiliation":[{"name":"Division of Molecular Microbiology and Immunology, Lucknow, Uttar Pradesh, India"},{"name":"Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Akhir","sequence":"additional","affiliation":[{"name":"Division of Molecular Microbiology and Immunology, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjulika","family":"Shukla","sequence":"additional","affiliation":[{"name":"Division of Molecular Microbiology and Immunology, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasham","family":"Shafi","sequence":"additional","affiliation":[{"name":"Division of Pharmaceutics &amp; Pharmacokinetics, CSIR-Central Drug Research Institute, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravikumar","family":"Akunuri","sequence":"additional","affiliation":[{"name":"Department of Chemical Sciences, NIPER Hyderabad, Hyderabad, Telengana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Pawar","sequence":"additional","affiliation":[{"name":"Department of Chemical Sciences, NIPER Hyderabad, Hyderabad, Telengana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahammad","family":"Ghouse","sequence":"additional","affiliation":[{"name":"Department of Chemical Sciences, NIPER Hyderabad, Hyderabad, Telengana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanduri","family":"Srinivas","sequence":"additional","affiliation":[{"name":"Department of Chemical Sciences, NIPER Hyderabad, Hyderabad, Telengana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8823-6074","authenticated-orcid":true,"given":"Sidharth","family":"Chopra","sequence":"additional","affiliation":[{"name":"Division of Molecular Microbiology and Immunology, Lucknow, Uttar Pradesh, India"},{"name":"Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","unstructured":"WHO. 2017. WHO publishes list of bacteria for which new antibiotics are urgently needed. https:\/\/www.who.int\/publications\/i\/item\/WHO-EMP-IAU-2017.12. Accessed 21 October 2022."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.abl5997"},{"key":"e_1_3_2_4_2","unstructured":"O\u2019Neill J. 2016. Tackling drug-resistant infections globally: final report and recommendations. https:\/\/amr-review.org\/sites\/default\/files\/160518_Final%20paper_with%20cover.pdf. Accessed 21 October 2022."},{"key":"e_1_3_2_5_2","unstructured":"WHO. 2020. Lack of new antibiotics threatens global efforts to contain drug-resistant infections https:\/\/www.who.int\/news\/item\/17-01-2020-lack-of-new-antibiotics-threatens-global-efforts-to-contain-drug-resistant-infections. Accessed 21 October 2022."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02724-0"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1211.060190"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12718"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz002"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu658"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00134-14"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.2217\/fmb-2019-0122"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-019-0357-1"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-018-0141-x"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm020980t"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.200700066"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/hlca.200900051"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2008.01.006"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/hlca.201100189"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2010.10.011"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.70679"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.5b00097"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2018.12.009"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/0471141755.ph13a08s50"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2202"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0738-081x(89)90017-5"},{"key":"e_1_3_2_27_2","first-page":"126","article-title":"Oxiconazole nitrate: pharmacology, efficacy, and safety of a new imidazole antifungal agent","volume":"13","author":"Jegasothy BV","year":"1991","unstructured":"Jegasothy BV, Pakes GE. 1991. Oxiconazole nitrate: pharmacology, efficacy, and safety of a new imidazole antifungal agent. Clin Ther 13:126\u2013141.","journal-title":"Clin Ther"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1159\/000248837"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.1.2.187"},{"key":"e_1_3_2_30_2","first-page":"17","article-title":"Oxiconazole, a new imidazole derivative. Evaluation of antifungal activity in vitro and in vivo","volume":"32","author":"Polak A","year":"1982","unstructured":"Polak A. 1982. Oxiconazole, a new imidazole derivative. Evaluation of antifungal activity in vitro and in vivo. Arzneimittelforschung 32:17\u201324.","journal-title":"Arzneimittelforschung"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1159\/000238275"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0732-8893(88)90114-9"},{"key":"e_1_3_2_33_2","unstructured":"FDA. Oxiconazole nitrate cream 1%. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/205076Orig1s000lbl.pdf. Accessed 21 October 2022."},{"key":"e_1_3_2_34_2","unstructured":"Padagis Israel Pharmaceuticals Ltd. Gentamicin sulfate: gentamicin sulfate ointment. https:\/\/dailymed.nlm.nih.gov\/dailymed\/fda\/fdaDrugXsl.cfm?setid=a9486ae1-350b-41c5-ae0c-a4d692bb2dfd&type=display. Accessed 21 October 2022."},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/3.3.213"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.30.2.165"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.3747\/pdi.2011.00224"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3476(80)80439-2"},{"key":"e_1_3_2_39_2","volume-title":"Performance standards for antimicrobial susceptibility testing","author":"CLSI","year":"2020","unstructured":"CLSI. 2020. Performance standards for antimicrobial susceptibility testing, 30th ed. M100. CLSI, Wayne, PA.","edition":"30"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/srep22571"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkac201"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg301"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jnatprod.2c00621"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/0196-4399(91)90030-Y"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/47.5.589"}],"container-title":["Microbiology Spectrum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.05031-22","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.05031-22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T13:14:52Z","timestamp":1692278092000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/spectrum.05031-22"}},"subtitle":[],"editor":[{"given":"Meera","family":"Unnikrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,8,17]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8,17]]}},"alternative-id":["10.1128\/spectrum.05031-22"],"URL":"https:\/\/doi.org\/10.1128\/spectrum.05031-22","relation":{},"ISSN":["2165-0497"],"issn-type":[{"value":"2165-0497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,17]]},"assertion":[{"value":"2022-12-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-10","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e05031-22"}}